Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- Interventions
- Device: BUFY01 eye drops in single-dose containersDevice: SVS20 eye drops in single-dose containers
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865379
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
Not Applicable
Not yet recruiting
- Conditions
- Dry Eye Disease
- Interventions
- Device: TRB02 eye drops in single-dose containersDevice: BUFY02 eye drops in single-dose containers
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 80
- Registration Number
- NCT05865457
Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis
Phase 3
Completed
- Conditions
- OsteoarthritisOsteoarthritis, Knee
- Interventions
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- TRB Chemedica International SA
- Target Recruit Count
- 380
- Registration Number
- NCT02688400
- Locations
- 🇨🇿
Affidea Praha, s.r.o., Prague, Czechia
🇪🇸Rheumatology Hospital Universitario A Coruna, A Coruna, Spain
🇧🇪Institut Médical Spécialisé - Centre DISCCA, Hornu, Belgium
© Copyright 2025. All Rights Reserved by MedPath